Physician profile
Ashley Ledson
NPI 1902465271
$9,589.91
in general payments reported to CMS, 2019-2025
32 companies · $1,562 in 2025
The $1,562 reported for 2025 was more than what 92% of Family providers received nationally (typical 2025 total: $167).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $864 · 2022: $2,294 · 2023: $2,558 · 2024: $2,312 · 2025: $1,562.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $6,432.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $6,432.27 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Glaxosmithkline, LLC. | $2,047.56 | 2021-2025 | Trelegy Ellipta, Nucala, Arexvy |
| Astrazeneca Pharmaceuticals LP | $1,368.33 | 2021-2025 | Fasenra, Airsupra, Breztri |
| Grifols USA, LLC | $733.54 | 2021-2025 | Prolastin-C Liquid |
| Boehringer Ingelheim Pharmaceuticals, INC. | $725.76 | 2021-2025 | Ofev, Jardiance |
| Regeneron Healthcare Solutions, INC. | $551.60 | 2022-2025 | Dupixent |
| Takeda Pharmaceuticals U.S.A., INC. | $467.80 | 2021-2025 | Glassia, Hyqvia |
| Novartis Pharmaceuticals Corporation | $388.93 | 2022-2024 | |
| Genzyme Corporation | $366.50 | 2022-2025 | |
| Pulmonx Corporation | $351.81 | 2022-2024 | Pulmonx Chartis Tablet Console, Zephyr Delivery Catheter, Chartis Catheter |
| Genentech USA, INC. | $329.65 | 2022-2025 | Xolair |
| United Therapeutics Corporation | $300.22 | 2021-2025 | Tyvaso, Tyvaso |
| Mylan Specialty L.P. | $246.27 | 2022-2023 | Yupelri |
| Electromed, INC. | $198.23 | 2021-2025 | Smartvest |
| Inspire Medical Systems, INC. | $160.91 | 2024-2025 | Inspire |
| Viatris Specialty LLC | $154.09 | 2025 | Yupelri |
Show all 32 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Actelion Pharmaceuticals US, INC. | $150.00 | 2024 | Uptravi, Opsumit |
| Verona Pharma, INC. | $141.88 | 2025 | Ohtuvayre |
| Jazz Pharmaceuticals INC. | $138.27 | 2021-2023 | |
| Amgen INC. | $128.24 | 2023-2025 | Tezspire, Evenity, Prolia |
| Philips North America LLC | $125.20 | 2022-2025 | (Ak6) Vest Therapy, Vest Therapy Und |
| Teva Pharmaceuticals USA, INC. | $112.86 | 2022 | |
| Axsome Therapeutics, INC. | $97.01 | 2023-2025 | Sunosi |
| Bayer Healthcare Pharmaceuticals INC. | $90.74 | 2022-2025 | |
| Baxter Healthcare | $39.88 | 2022 | |
| Vifor Pharma, INC. | $32.61 | 2025 | Zemaira |
| Janssen Pharmaceuticals, INC | $26.57 | 2022 | |
| Paratek Pharmaceuticals, INC. | $25.79 | 2023 | Nuzyra |
| Insmed, INC. | $23.45 | 2025 | Arikayce |
| Tactile Systems Technology INC | $20.65 | 2024 | Entre Plus, Flexitouch Plus |
| Inogen, INC. | $16.29 | 2023 | Inogen One G5 Oxygen Concentrator - Bluetooth |
| Phadia US INC. | $14.90 | 2022 | |
| Lilly USA, LLC | $14.37 | 2025 | Zepbound |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Ashley Ledson listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.